(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

USO DE UM PRODUTO DE IMUNOGLOBULINA PARA TRATAMENTO DE PDIC

Em ExigênciaInvention PatentPCT · EP2019063322

Application data

Number

112020022249

Type

Invention Patent

Filing

05/23/2019

Publication

02/23/2021

PCT

EP2019063322

Progress at the INPI

Technical opinion to answer
  1. Filing05/23/19
  2. Publication02/23/21
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The INPI issued a technical opinion on patentability. The applicant must respond for examination to continue.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 03/31/2026. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

CSL BEHRING AG

CH

See this company's full portfolio

Inventors

J. L. (pessoa física)

DE

V. B. (pessoa física)

CA

Technical data

Priority claims

EP

18173860.0 · 05/23/2018

Abstract

A presente invenção refere-se a uma terapia de imunoglobulina. Em particular, uma terapia de imunoglobulina para tratamento de CIDP com dano não axonal ou dano axonal suave é provida.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Parecer de pré-exame

#6.23

03/31/2026

RPI 2882

Adição na publicação

#15.35

12/14/2021

RPI 2658

Notificação de entrada na fase nacional - PCT

#1.3

02/23/2021

RPI 2616

Alteração de dados cadastrais

#1.1

11/10/2020

RPI 2601

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.